Showing results (151-160 of 2,817) with videos related to

Sort By:
Pageof 282
Journal of Medical Microbiology|February 1, 1992
An investigation of beta-lactamases from clinical isolates of Bacteroides speciesR Edwards, D Greenwood
The Journal of Applied Bacteriology|September 1, 1990
Effect of growth conditions and storage on the specific activity of beta-lactamases of Bacteroides sppR Edwards, D Greenwood
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Lung cancer treatment waiting times and tumour growthN O'Rourke, R Edwards
Revue Neurologique|April 27, 2002
[Characterization and discrimination of kinetic tremor in Parkinson's disease]A Beuter, R Edwards
The Journal of Tropical Medicine and Hygiene|February 1, 1978
Hepatic trauma and amoebic liver abscessS Ramachandran, R Edwards
British Journal of Haematology|August 1, 1990
Long-term prognostic value of serum beta 2 microglobulin in myelomatosisJ Cuzick, B L De Stavola, E H Cooper, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1987
A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrenceI S Fentiman, F R Balkwill, J Cuzick, et al.
Cancer|October 30, 2003
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analysesM Baum, A Buzdar, J Cuzick, et al.
British Journal of Cancer|November 13, 2008
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancerB Sherrill, M Amonkar, Y Wu, et al.
Lancet (London, England)|May 22, 2007
Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials, J Cuzick, L Ambroisine, et al.
Pageof 282